Navigation Links
Cord Blood may Hold Potential Therapy for Type 1 Diabetes

Boffins have found that umbilical cord blood might safely preserve insulin production in children newly diagnosed with type 1 diabetes.

The study was conducted by a team of researchers led by Dr. Michael Haller at the University of Florida.

As part of the study, researchers identified children recently diagnosed with type 1 diabetes whose families banked their umbilical cord blood at birth, and gave seven patients ages 2 to 7 intravenous infusions of stem cells isolated from their own cord blood.

Researchers evaluated the patients for the next two years to measure how much insulin they were making on their own and to assess blood sugar levels and the function of key immune system cells.

The study found that during the first six months, the children required significantly less insulin and maintained better control of blood sugar levels than children of comparable age with type 1 diabetes who were randomly selected from the clinic population.

The researchers also noted that the children who received cord blood infusions had higher levels of regulatory immune cells in their blood six months after the infusion.

"This is the first attempt at using cord blood as a potential therapy for type 1 diabetes. We hope these cells can either lessen the immune system's attack on the pancreas or possibly introduce stem cells that can differentiate into insulin-producing cells," Haller said.

"This isn't a cure-all. We think that giving these cells is essentially providing some immunotherapy and downregulating the autoimmunity these patients have," he added.

The findings of the study were presented at the American Diabetes Association's 67th Scientific Sessions in Chicago.


'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... 28, 2017 , ... The Lice Treatment Center® booth at ... was a busy spot this year. Liz Solovay and Adrian Picheny, the firm’s ... among camp communities during the upcoming 2017 camping season. “Lice infestations at some ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners and physician ... value increases in the healthcare workforce, according to a survey recently released by ... fairs, and candidate leads to healthcare employers of physicians and advanced practice clinicians. ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... patients for custom smile makeovers without requiring a referral. Trimble Dental ... gum disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, crooked ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... DIEGO and VANCOUVER, British Columbia, March 27, 2017 ... ) (the "Company" or "Sophiris"), a clinical late-stage ... of patients with urological diseases, today reported fourth ... key corporate highlights. Key Corporate ... Clinical Development for Localized Prostate Cancer. During 2016, ...
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... -- The staggering cost of cancer treatment means only ... the latest treatment options against cancer. Even among the ... inadequate or no health insurance and are oftentimes saddled ... modern cancer treatment is almost non-existent for cancer patients ... mission statements of pharmaceutical and biotech companies often quote ...
Breaking Medicine Technology: